LPA and cancer: In aggressive EC, the autotaxin–LPA axis contributes to tumor progression by fueling a pro-metastatic signaling loop: as LPA levels increase at the expense of LPC, LPA receptors on cancer cells drive processes like epithelial–mesenchymal transition, migration, and survival in the hostile circulation.